Here, we show that cell-free DNA and DNA-MPO levels remain elevated over the first forty-eight hours of illness and correlate with several clinical outcomes including illness severity, mortality, and ventilator-free days in patients with moderate-to-severe ARDS. This evidence concerns the gene MPO and acute respiratory distress syndrome.